Research on organoids is advancing in the field of personalized oncology, with potential applications in precision cancer therapy. Organoids are being explored for various types of cancer, including gastric, lung, and breast cancer, with some companies launching programs to advance personalized cancer care. The use of organoids in cancer research is being studied for its potential to improve disease modeling, clinical decision support, and cancer immunotherapy.